BioNTech SE (BNTX) shares tumbled 5.15% during pre-market trading on Tuesday, following the release of its second-quarter financial results that fell short of analyst expectations.
The company reported a quarterly adjusted loss of $2.58 per share, which was wider than the consensus estimate of a $2.34 loss per share. Revenue for the quarter came in at $122.77 million, significantly missing the $182.02 million that analysts had projected and marking a sharp decline from the $295.70 million reported in the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments